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AtrialFibrilation inPractice: GregoryYHLip: The Royal
Society of Medicine Press Limited. www.rsmpress.co.uk
ISBN 1-85315-484-9. £14.95 paperback, 72 pp.
Heart Failure in Practice: Bernard SP Chin, Michael K
Davis, Gregory YH Lip. The Royal Society of Medicine
Press Limited. www.rsmpress.co.uk
ISBN 1-85315-487-3. £14.95 paperback, 72 pp.
These two volumes form part of the excellent In Practice
series, published by the Royal Society of Medicine. Each
examines an aspect of cardiology and presents it in such a
way as tobe accessible fortheexpert and the generalist alike.
ProfessorLipis wellknown forhis workon atrial fibrillation,
andthebookmanages to include alotofinformation. Despite
this, it is very readable. My only concern is that there is
distincttrans-Atlantic flavourtotheprescribing. No local GP
willprescribeClass 1 antiarrhythmic drugs without specialist
advice, and so a detaileddiscussion ofthem is outofplace. In
addition, dofetilide is notlicensed intheUK. 1 feel the author
underestimates the long-term effects of amiodarone on the
lungs, and serial measurements of diffusion capacity would
be a more sensitive way ofdetecting these than chest X-rays.
Finally,Iwouldhavethoughtthatamentionoftheforthcoming
new anti-thrombin drugs would be appropriate, as warfarin
and all its problems could soon be a thing of the past!
In contrast, the volume on Heart Failure takes an altogether
simpler (or even simplistic) approach. This is fine, as long as
it does not lead to factual inaccuracies, such as the statement
(p. 22) that the skeletal muscle dysfunction in heart failure is
due to impaired blood flow. There are several topical areas
that areomitted, such as therole ofcardiopulmonary exercise
testing in the evaluation ofpatients, the use ofCPAP in acute
heart failure (see Table 8.2), or the role of biventricular
pacing. In addition, the relevant part ofthe NICE guidelines
for the treatment of coronary heart disease (Section 11),
although vague, could be added as an Appendix. In addition,
there are several small errors - Figure 2.2 is a poor example
ofLVH, as it only shows the voltage criteria; in Table 2.2, a
list of cardiotoxins, Adriamycin® is a trade name for
doxorubicin, so they are the same; on p.21, Figure 3.3 shows
the relationship of AVP with symptom severity, not
noradrenaline; finally, are crepitations in the lung found in
emphysema (p. 27)? Overallthen, auseful introduction to the
subjectforthenon-expert, buthopefully withthe nextedition
some of the errors and omissions can be corrected.
D P NICHOLS
Mental Health in Older People in Practice: Alistair Burns,
Nitin Purandare, Sarah Craig. The Royal Society of
Medicine Press Limited. www.rsmpress.co.uk
ISBN 1-85315-515-2. £14.95 paperback. 61pp.
Given the steady increase in the population aged over 65
years, health care staff in most specialities require some
knowledge of mental health problems in older people. This
short bookis clearly setout andprovides aconcise accountof
depression, dementia, delirium and other common mental
health disorders found in older people. A useful chapter
entitled 'ApproachtoSpecificProblems' providesbriefadvice
on how to deal with the aggressive patient, the confused
patient, the patient found wandering and the mentally ill
patient who refuses treatment. These practical topics are a
welcome inclusion, but unfortunately are dealt with a little
too briefly. Similarly a chapter entitled 'Legal and Ethical
Issues' covers areas such as mental capacity, advance
directives andinformedconsent, whichareextremelyrelevant
topics to the practicing clinician, but unfortunately they have
not been dealt with in sufficient detail. In summary this is a
useful synopsis which could serve as an introductory text for
undergraduate students andthosewhorequire abriefoverview
of mental health disorders in older people. The range of
topics covered are relevant to clinical practice.
M I WIGGAN
Parkinson's disease in Practice: by Carl E Clarke pp1O3,
RSM press 2001. ISBN 1-85315-486-5.
In the olden days neurologists, those virtuosi of the clinical
method, were often ridiculed for the lack of effective
treatments for interesting but terrible and disabling
neurological diseases. Then inthe late 1960s the discovery of
low levels of dopamine in the basal ganglia in Parkinson's
disease rapidly lead to the introduction of levodopa with
dramatic palliation of many of the motor symptoms of the
disease. This was the first truly rational treatment for a
degenerative neurological condition. There are now a score
ofdifferent drugs and a variety ofoperations used to treatthe
disorder. There are new imaging and physiological methods
toaiddiagnosisandoveradozengeneslinkedtothecondition.
In fact neurologists now have such a large range oftreatment
that have caused headaches for health service planners. But
this is good news for our patients. Carl Clarke succeeds in
distillingjust over a hundred pages ofpragmatic and readily
digestible useful information from a vast amount ofdata. The
author has a particular interest in evidence based medicine
which is invaluable when considering an area with so many
claims ofefficacy. This rigorous approach is also applied to
the sections on surgery and physiotherapy which tend to be
accepted with less careful thought than drugs. The slim
volume is well produced and suitably illustrated. It contains
more than enough for anyone interested in this common
disease, it is well referenced for those wishing to learn more,
and is much more accessible than the internet.
J M GIBSON
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